Block listing Interim Review

RNS Number : 7281N
GlaxoSmithKline PLC
10 May 2018
 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 10 May 2018

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan

Period of return:

From:

1 November 2017

To:

30 April 2018

Balance of unallotted securities under scheme(s) from previous return:

199,082

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

165,219

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

33,863

         

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 10 May 2018

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - Ordinary Shares

Period of return:

From:

1 November 2017

To:

30 April 2018

Balance of unallotted securities under scheme(s) from previous return:

3,559,772

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

865,821

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,693,951

 

         

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 10 May 2018

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - ADS

Period of return:

From:

1 November 2017

To:

30 April 2018

Balance of unallotted securities under scheme(s) from previous return:

8,185,120

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

275,126

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

7,909,994

         

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 10 May 2018

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2012

Period of return:

From:

1 November 2017

To:

30 April 2018

Balance of unallotted securities under scheme(s) from previous return:

1,542,070

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

714,764

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

827,306

         

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 

The following GlaxoSmithKline plc Employee Share Schemes have expired and therefore will no longer be included in Block Listing Six Monthly Returns:

 

1.   Glaxo Wellcome UK Share Option Scheme

2.   Glaxo Wellcome International Share Option Scheme

3.   Glaxo Wellcome 1999 Share Option Plan

4.   SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares

5.   SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS

6.   SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRMMGMKVGVGRZM

Companies

GSK (GSK)
UK 100

Latest directors dealings